Scott Gottlieb has been picked by Trump to head the US Food & Drug Administration. This post from Doctor Frank highlights what this means for medical cannabis. So, it looks like Scott Gottlieb, MD, will be appointed Director of the Food & Drug Administration (FDA), much to the cheer of those in the pharmaceutical and biotech industries. Gottlieb seems to favor faster ... Continue Reading
Big pharma
DEA Colludes with Big Pharma to Schedule CBD
The shocking story erupting over the last few days has been the DEA trying to classify all components of cannabis as a Schedule I substance. Specifically targeting cannabidiol (CBD), a compound that the UK calls a “medicine” and countless patients around the world use regularly to help a variety of symptoms. Schedule I drugs, substances, or chemicals are defined as drugs ... Continue Reading
Legal Marijuana Causing Concern Among BigPharma
New research shows a dramatic drop in painkiller prescriptions after medical marijuana laws are passed. This article from The Washington Post turns the spot light on one striking chart that shows why pharma companies are fighting legal marijuana. There's a body of research showing that painkiller abuse and overdose are lower in states with medical marijuana laws. These ... Continue Reading
Big Pharma Swooping in to Monopolize the CBD Market
While regulators debate the legal status of cannabis-derived compound, CBD, Big Pharma attempts to corner the market. This post from TruthOut highlights how Big Pharma seeks to capitalize on the pain-reducing compounds derived from cannabis. The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly ... Continue Reading
80% Of Cannabis Users Substitute Cannabis for Prescription Drugs
The most startling revelation of a recent survey is that 80% of respondents reported substituting cannabis for prescription drugs. This post from Pain Treatment Solution states that this result is a cause for Big Pharma’s displeasure and could have them running to their crony lawmakers. Big Pharma must be getting seriously worried by the results of a recent survey conducted ... Continue Reading